| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.805 | 0.003 | 0.805 | Alcohol oxidase inhibitor | 0.089 0.021 CID_171625 0.071 0.028 CID_6453558 | ||
| 0.784 | 0.005 | 0.784 | Aldehyde oxidase inhibitor | 0.512 0.031 CID_171625 | ||
| 0.735 | 0.003 | 0.735 | Alpha-N-acetylglucosaminidase inhibitor | 0.357 0.011 CID_171625 0.714 0.003 CID_6453558 | ||
| 0.684 | 0.009 | 0.842 | Cholesterol antagonist | 0.457 0.039 CID_171625 0.842 0.003 CID_6453558 | CID_6453558 | |
| 0.675 | 0.002 | 0.675 | Succinate dehydrogenase inhibitor | 0.337 0.006 CID_171625 0.213 0.04 CID_6453558 | ||
| 0.634 | 0.007 | 0.634 | 5 Hydroxytryptamine release inhibitor | 0.467 0.044 CID_171625 0.521 0.026 CID_6453558 | ||
| 0.625 | 0.006 | 0.625 | Superoxide dismutase inhibitor | 0.437 0.021 CID_171625 | ||
| 0.607 | 0.003 | 0.607 | 5 Hydroxytryptamine uptake stimulant | 0.469 0.005 CID_171625 0.259 0.073 CID_6453558 | ||
| 0.599 | 0.01 | 0.609 | Histamine release inhibitor | 0.466 0.042 CID_171625 0.609 0.009 CID_6453558 | CID_6453558 | |
| 0.561 | 0.003 | 0.561 | Porphobilinogen synthase inhibitor | 0.184 0.014 CID_171625 | ||
| 0.566 | 0.013 | 0.566 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.472 0.048 CID_171625 | ||
| 0.553 | 0.006 | 0.583 | Peroxidase inhibitor | 0.583 0.005 CID_171625 | CID_171625 | |
| 0.527 | 0.003 | 0.527 | GABA C receptor agonist | 0.296 0.01 CID_171625 | ||
| 0.5 | 0.004 | 0.5 | Cystathionine beta-synthase inhibitor | 0.194 0.026 CID_171625 0.287 0.011 CID_6453558 | ||
| 0.532 | 0.042 | 0.823 | Cyclophilin D inhibitor | 0.449 0.067 CID_171625 0.823 0.005 CID_6453558 | CID_6453558 | |
| 0.466 | 0.007 | 0.466 | Phospholipase C inhibitor | 0.422 0.009 CID_171625 0.275 0.021 CID_6453558 | ||
| 0.485 | 0.03 | 0.527 | GABA C receptor rho-3 antagonist | 0.527 0.019 CID_171625 | CID_171625 | |
| 0.453 | 0.003 | 0.482 | Triose-phosphate isomerase inhibitor | 0.156 0.018 CID_171625 0.482 0.003 CID_6453558 | CID_6453558 | |
| 0.473 | 0.039 | 0.473 | Calcium channel L-type activator | 0.342 0.123 CID_171625 | ||
| 0.431 | 0.003 | 0.431 | Ferrochelatase inhibitor | 0.17 0.03 CID_171625 | ||
| 0.427 | 0.003 | 0.427 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.129 0.034 CID_171625 0.397 0.004 CID_6453558 | ||
| 0.432 | 0.015 | 0.432 | Calcium channel activator | 0.285 0.107 CID_171625 0.24 0.159 CID_6453558 | ||
| 0.436 | 0.022 | 0.705 | Hypoglycemic | 0.333 0.042 CID_171625 0.705 0.005 CID_6453558 | CID_6453558 | |
| 0.417 | 0.007 | 0.417 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.325 0.017 CID_171625 0.32 0.018 CID_6453558 | ||
| 0.412 | 0.005 | 0.477 | UDP-glucose 4-epimerase inhibitor | 0.105 0.055 CID_171625 0.477 0.003 CID_6453558 | CID_6453558 | |
| 0.419 | 0.012 | 0.48 | Sodium/bile acid cotransporter inhibitor | 0.48 0.005 CID_171625 0.312 0.068 CID_6453558 | CID_171625 | |
| 0.4 | 0.004 | 0.4 | Histidine decarboxylase inhibitor | 0.253 0.009 CID_171625 | ||
| 0.394 | 0.003 | 0.394 | Glutamate decarboxylase inhibitor | 0.214 0.006 CID_171625 0.073 0.051 CID_6453558 | ||
| 0.432 | 0.046 | 0.588 | Vasodilator, peripheral | 0.588 0.017 CID_6453558 | CID_6453558 | |
| 0.381 | 0.01 | 0.473 | Tyrosine 3 hydroxylase inhibitor | 0.473 0.004 CID_171625 | CID_171625 | |
| 0.369 | 0.011 | 0.696 | Amylase inhibitor | 0.235 0.032 CID_171625 0.696 0.003 CID_6453558 | CID_6453558 | |
| 0.376 | 0.023 | 0.486 | Interleukin agonist | 0.304 0.046 CID_171625 0.486 0.01 CID_6453558 | CID_6453558 | |
| 0.365 | 0.014 | 0.365 | Mcl-1 antagonist | 0.129 0.113 CID_171625 0.125 0.118 CID_6453558 | ||
| 0.355 | 0.004 | 0.355 | Leukotriene A4 hydrolase inhibitor | 0.094 0.006 CID_171625 | ||
| 0.352 | 0.006 | 0.358 | Hexokinase inhibitor | 0.167 0.061 CID_171625 0.358 0.005 CID_6453558 | CID_6453558 | |
| 0.348 | 0.004 | 0.348 | Phenylalanine 4-hydroxylase inhibitor | 0.191 0.007 CID_171625 0.063 0.053 CID_6453558 | ||
| 0.365 | 0.021 | 0.415 | Anesthetic general | 0.415 0.014 CID_6453558 | CID_6453558 | |
| 0.341 | 0.002 | 0.341 | Aconitate hydratase inhibitor | 0.101 0.008 CID_171625 0.05 0.038 CID_6453558 | ||
| 0.344 | 0.013 | 0.344 | Protein-tyrosine phosphatase inhibitor | 0.154 0.074 CID_171625 0.3 0.019 CID_6453558 | ||
| 0.383 | 0.054 | 0.753 | Antithrombotic | 0.433 0.042 CID_171625 0.753 0.005 CID_6453558 | CID_6453558 | |
| 0.394 | 0.065 | 0.775 | Transcription factor NF kappa B inhibitor | 0.262 0.119 CID_171625 0.775 0.015 CID_6453558 | CID_6453558 | |
| 0.33 | 0.004 | 0.33 | Electrolyte absorption antagonist | 0.18 0.011 CID_171625 | ||
| 0.329 | 0.006 | 0.497 | NADH dehydrogenase inhibitor | 0.134 0.022 CID_171625 0.497 0.003 CID_6453558 | CID_6453558 | |
| 0.328 | 0.006 | 0.328 | Carbonic anhydrase XV inhibitor | 0.091 0.082 CID_171625 | ||
| 0.325 | 0.004 | 0.325 | Macrophage migration inhibitory factor inhibitor | 0.085 0.045 CID_171625 | ||
| 0.323 | 0.004 | 0.323 | Creatine kinase inhibitor | 0.116 0.044 CID_171625 0.088 0.075 CID_6453558 | ||
| 0.322 | 0.003 | 0.322 | GABA aminotransferase inhibitor | 0.117 0.017 CID_171625 0.189 0.005 CID_6453558 | ||
| 0.33 | 0.017 | 0.348 | Gastrin inhibitor | 0.348 0.011 CID_171625 0.238 0.093 CID_6453558 | CID_171625 | |
| 0.318 | 0.01 | 0.318 | Aldehyde dehydrogenase inhibitor | 0.224 0.023 CID_171625 0.183 0.032 CID_6453558 | ||
| 0.411 | 0.105 | 0.533 | Caspase 9 stimulant | 0.34 0.154 CID_171625 0.533 0.049 CID_6453558 | CID_6453558 | |
| 0.428 | 0.122 | 0.857 | Antiinflammatory | 0.857 0.009 CID_6453558 | CID_6453558 | |
| 0.317 | 0.011 | 0.317 | Phospholipase A2 inhibitor | 0.227 0.03 CID_171625 0.217 0.035 CID_6453558 | ||
| 0.356 | 0.052 | 0.547 | Vasodilator, coronary | 0.273 0.112 CID_171625 0.547 0.011 CID_6453558 | CID_6453558 | |
| 0.341 | 0.037 | 0.35 | Insulysin inhibitor | 0.35 0.034 CID_171625 | CID_171625 | |
| 0.327 | 0.024 | 0.327 | Dual specificity phosphatase 3 inhibitor | |||
| 0.307 | 0.005 | 0.307 | Carbonic anhydrase III inhibitor | 0.127 0.04 CID_171625 0.145 0.03 CID_6453558 | ||
| 0.305 | 0.004 | 0.305 | Keratolytic | 0.103 0.029 CID_171625 0.075 0.056 CID_6453558 | ||
| 0.337 | 0.037 | 0.337 | Transcription factor STAT3 inhibitor | 0.234 0.097 CID_171625 0.21 0.122 CID_6453558 | ||
| 0.306 | 0.007 | 0.306 | Adenylate kinase inhibitor | 0.157 0.024 CID_171625 0.185 0.017 CID_6453558 | ||
| 0.323 | 0.025 | 0.323 | Dual specificity phosphatase inhibitor | |||
| 0.381 | 0.086 | 0.634 | Antibacterial | 0.634 0.015 CID_6453558 | CID_6453558 | |
| 0.349 | 0.057 | 0.349 | 12-Lipoxygenase inhibitor | 0.204 0.147 CID_171625 | ||
| 0.305 | 0.015 | 0.305 | Insulin sensitizer | 0.291 0.018 CID_171625 0.227 0.05 CID_6453558 | ||
| 0.333 | 0.043 | 0.692 | Free radical scavenger | 0.209 0.09 CID_171625 0.692 0.005 CID_6453558 | CID_6453558 | |
| 0.312 | 0.026 | 0.562 | Non-steroidal antiinflammatory agent | 0.201 0.07 CID_171625 0.562 0.005 CID_6453558 | CID_6453558 | |
| 0.29 | 0.004 | 0.29 | HIV-1 integrase (Overall Integration) inhibitor | 0.262 0.004 CID_171625 | ||
| 0.339 | 0.054 | 0.339 | Lipoxygenase inhibitor | 0.185 0.156 CID_171625 | ||
| 0.285 | 0.003 | 0.285 | DOPA decarboxylase inhibitor | 0.163 0.016 CID_171625 0.101 0.073 CID_6453558 | ||
| 0.29 | 0.008 | 0.389 | Xanthine oxidase inhibitor | 0.099 0.06 CID_171625 0.389 0.005 CID_6453558 | CID_6453558 | |
| 0.304 | 0.025 | 0.307 | DNA methyltransferase I inhibitor | 0.242 0.05 CID_171625 0.307 0.024 CID_6453558 | CID_6453558 | |
| 0.283 | 0.004 | 0.283 | Biliverdin reductase inhibitor | 0.081 0.025 CID_171625 0.101 0.018 CID_6453558 | ||
| 0.297 | 0.018 | 0.575 | Monophenol monooxygenase inhibitor | 0.171 0.04 CID_171625 0.575 0.005 CID_6453558 | CID_6453558 | |
| 0.298 | 0.02 | 0.377 | Interferon gamma antagonist | 0.14 0.093 CID_171625 0.377 0.012 CID_6453558 | CID_6453558 | |
| 0.316 | 0.039 | 0.445 | DNA synthesis inhibitor | 0.222 0.092 CID_171625 0.445 0.017 CID_6453558 | CID_6453558 | |
| 0.319 | 0.043 | 0.407 | Hypolipemic | 0.24 0.072 CID_171625 0.407 0.024 CID_6453558 | CID_6453558 | |
| 0.281 | 0.006 | 0.281 | Glutamate dehydrogenase inhibitor | 0.133 0.019 CID_171625 0.108 0.027 CID_6453558 | ||
| 0.293 | 0.02 | 0.3 | Neurotrophic factor enhancer | 0.3 0.018 CID_171625 0.283 0.023 CID_6453558 | CID_171625 | |
| 0.313 | 0.049 | 0.313 | Transcription factor STAT inhibitor | 0.199 0.139 CID_171625 | ||
| 0.274 | 0.014 | 0.274 | Cholesterol synthesis inhibitor | 0.158 0.041 CID_171625 0.176 0.034 CID_6453558 | ||
| 0.272 | 0.013 | 0.281 | Protein-tyrosine phosphatase 1B inhibitor | 0.281 0.012 CID_6453558 | CID_6453558 | |
| 0.266 | 0.009 | 0.266 | Mannose-6-phosphate isomerase inhibitor | 0.133 0.082 CID_171625 0.262 0.01 CID_6453558 | ||
| 0.273 | 0.019 | 0.273 | 3C-like protease (Human coronavirus) inhibitor | 0.155 0.093 CID_171625 | ||
| 0.257 | 0.006 | 0.257 | Uric acid excretion stimulant | 0.196 0.014 CID_6453558 | ||
| 0.252 | 0.003 | 0.252 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.101 0.016 CID_171625 0.169 0.005 CID_6453558 | ||
| 0.252 | 0.004 | 0.252 | Sphingosine 1-phosphate receptor 5 antagonist | 0.173 0.03 CID_171625 | ||
| 0.281 | 0.034 | 0.348 | DNA methylase inhibitor | 0.229 0.06 CID_171625 0.348 0.017 CID_6453558 | CID_6453558 | |
| 0.249 | 0.005 | 0.249 | Prostaglandin E2 antagonist | |||
| 0.27 | 0.026 | 0.27 | Amyloid beta precursor protein antagonist | 0.134 0.12 CID_171625 | ||
| 0.247 | 0.006 | 0.247 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.139 0.094 CID_171625 | ||
| 0.269 | 0.028 | 0.269 | Lipocortins synthesis antagonist | 0.147 0.109 CID_6453558 | ||
| 0.304 | 0.063 | 0.304 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.153 0.139 CID_171625 | ||
| 0.302 | 0.061 | 0.735 | Antioxidant | 0.218 0.102 CID_171625 0.735 0.005 CID_6453558 | CID_6453558 | |
| 0.262 | 0.023 | 0.378 | Protein kinase stimulant | 0.145 0.071 CID_171625 0.378 0.01 CID_6453558 | CID_6453558 | |
| 0.247 | 0.012 | 0.247 | Farnesoid X receptor antagonist | 0.178 0.03 CID_171625 | ||
| 0.241 | 0.01 | 0.486 | Cyclooxygenase 3 inhibitor | 0.159 0.041 CID_171625 0.486 0.003 CID_6453558 | CID_6453558 | |
| 0.237 | 0.009 | 0.237 | Alcohol dehydrogenase inhibitor | 0.126 0.031 CID_171625 0.106 0.046 CID_6453558 | ||
| 0.232 | 0.005 | 0.232 | Nav1.8 sodium channel blocker | 0.075 0.048 CID_171625 | ||
| 0.227 | 0.005 | 0.227 | Sphingosine 1-phosphate receptor 2 antagonist | 0.174 0.018 CID_171625 | ||
| 0.232 | 0.01 | 0.232 | Carbonic anhydrase VI inhibitor | 0.095 0.043 CID_171625 0.107 0.035 CID_6453558 | ||
| 0.276 | 0.054 | 0.276 | Pyruvate kinase inhibitor | |||
| 0.225 | 0.004 | 0.225 | Plasminogen activator inhibitor antagonist | 0.092 0.012 CID_171625 | ||
| 0.321 | 0.101 | 0.335 | Calpain 2 inhibitor | 0.335 0.094 CID_171625 | CID_171625 | |
| 0.29 | 0.07 | 0.351 | Hypoxia-inducible factor 1 alpha inhibitor | 0.282 0.075 CID_171625 0.351 0.044 CID_6453558 | CID_6453558 | |
| 0.302 | 0.084 | 0.627 | Apoptosis antagonist | 0.312 0.078 CID_171625 0.627 0.007 CID_6453558 | CID_6453558 | |
| 0.287 | 0.074 | 0.287 | 5 Hydroxytryptamine release stimulant | 0.167 0.156 CID_171625 0.249 0.089 CID_6453558 | ||
| 0.219 | 0.007 | 0.219 | Argininosuccinate synthase inhibitor | 0.068 0.031 CID_171625 0.078 0.026 CID_6453558 | ||
| 0.231 | 0.02 | 0.378 | Cell wall synthesis inhibitor | 0.157 0.059 CID_171625 0.378 0.007 CID_6453558 | CID_6453558 | |
| 0.301 | 0.093 | 0.453 | Thyroid hormone antagonist | 0.453 0.042 CID_171625 | CID_171625 | |
| 0.217 | 0.012 | 0.217 | Catalase inhibitor | 0.165 0.023 CID_171625 | ||
| 0.263 | 0.058 | 0.337 | Cyclic AMP phosphodiesterase inhibitor | 0.337 0.029 CID_6453558 | CID_6453558 | |
| 0.252 | 0.048 | 0.252 | RNA-directed DNA polymerase inhibitor | 0.199 0.101 CID_6453558 | ||
| 0.221 | 0.017 | 0.221 | Arachidonic acid antagonist | 0.178 0.056 CID_171625 0.165 0.071 CID_6453558 | ||
| 0.213 | 0.009 | 0.58 | AMP-activated protein kinase stimulant | 0.135 0.038 CID_171625 0.58 0.003 CID_6453558 | CID_6453558 | |
| 0.211 | 0.008 | 0.211 | ABCA1 expression enhancer | 0.097 0.054 CID_171625 | ||
| 0.241 | 0.039 | 0.327 | Nitric-oxide synthase stimulant | 0.327 0.007 CID_171625 0.243 0.038 CID_6453558 | CID_171625 | |
| 0.203 | 0.003 | 0.203 | Ca2+-transporting ATPase inhibitor | 0.138 0.083 CID_171625 0.183 0.006 CID_6453558 | ||
| 0.318 | 0.119 | 0.318 | 15-Lipoxygenase inhibitor | |||
| 0.209 | 0.01 | 0.263 | Phosphofructokinase-1 inhibitor | 0.08 0.041 CID_171625 0.263 0.007 CID_6453558 | CID_6453558 | |
| 0.217 | 0.021 | 0.217 | Catenin beta inhibitor | 0.16 0.084 CID_171625 | ||
| 0.228 | 0.032 | 0.4 | Melanin inhibitor | 0.169 0.06 CID_171625 0.4 0.012 CID_6453558 | CID_6453558 | |
| 0.202 | 0.008 | 0.202 | GABA C receptor rho-1 antagonist | 0.175 0.013 CID_171625 | ||
| 0.23 | 0.036 | 0.23 | Histone acetyltransferase inhibitor | 0.182 0.097 CID_171625 | ||
| 0.281 | 0.088 | 0.524 | Interleukin 2 agonist | 0.272 0.096 CID_171625 0.524 0.005 CID_6453558 | CID_6453558 | |
| 0.211 | 0.019 | 0.211 | Aminopeptidase B inhibitor | 0.188 0.024 CID_171625 | ||
| 0.194 | 0.005 | 0.194 | Ornithine decarboxylase inhibitor | 0.12 0.026 CID_171625 0.106 0.038 CID_6453558 | ||
| 0.202 | 0.013 | 0.225 | Mucolytic | 0.225 0.009 CID_171625 0.221 0.01 CID_6453558 | CID_171625 | |
| 0.199 | 0.011 | 0.199 | TRPA1 agonist | 0.135 0.043 CID_171625 0.114 0.066 CID_6453558 | ||
| 0.212 | 0.023 | 0.216 | GABA C receptor rho-2 antagonist | 0.216 0.021 CID_171625 | CID_171625 | |
| 0.239 | 0.051 | 0.239 | Sigma receptor agonist | |||
| 0.195 | 0.007 | 0.195 | Heat shock protein 70 antagonist | 0.135 0.096 CID_171625 0.158 0.03 CID_6453558 | ||
| 0.206 | 0.019 | 0.486 | Expectorant | 0.207 0.019 CID_171625 0.486 0.004 CID_6453558 | CID_6453558 | |
| 0.191 | 0.004 | 0.191 | Bile acid receptor antagonist | 0.134 0.011 CID_171625 0.112 0.028 CID_6453558 | ||
| 0.192 | 0.006 | 0.192 | Acyl-CoA dehydrogenase inhibitor | 0.069 0.027 CID_171625 0.058 0.035 CID_6453558 | ||
| 0.193 | 0.01 | 0.193 | Sphingosine 1-phosphate receptor 4 antagonist | 0.125 0.064 CID_171625 | ||
| 0.197 | 0.014 | 0.197 | Carbonic anhydrase XIII inhibitor | 0.098 0.039 CID_6453558 | ||
| 0.194 | 0.014 | 0.194 | GABA C receptor antagonist | 0.163 0.024 CID_171625 | ||
| 0.208 | 0.03 | 0.208 | M17 leucyl aminopeptidase inhibitor | |||
| 0.182 | 0.005 | 0.182 | Xanthine dehydrogenase inhibitor | 0.084 0.022 CID_6453558 | ||
| 0.209 | 0.032 | 0.423 | Insulin secretagoues | 0.177 0.05 CID_171625 0.423 0.005 CID_6453558 | CID_6453558 | |
| 0.179 | 0.003 | 0.179 | Glutamate (mGluR6) antagonist | 0.078 0.026 CID_171625 0.068 0.044 CID_6453558 | ||
| 0.191 | 0.017 | 0.191 | Potassium channel (Ca-activated) activator | 0.095 0.059 CID_171625 | ||
| 0.189 | 0.017 | 0.425 | Mediator release inhibitor | 0.106 0.062 CID_171625 0.425 0.005 CID_6453558 | CID_6453558 | |
| 0.177 | 0.005 | 0.177 | Purinergic P2X1 antagonist | 0.06 0.044 CID_171625 0.102 0.016 CID_6453558 | ||
| 0.179 | 0.008 | 0.179 | Peroxisome proliferator-activated receptor gamma agonist | 0.133 0.017 CID_171625 0.073 0.046 CID_6453558 | ||
| 0.195 | 0.026 | 0.222 | Toll-Like receptor 2 antagonist | 0.222 0.015 CID_171625 0.106 0.095 CID_6453558 | CID_171625 | |
| 0.258 | 0.088 | 0.452 | Spasmolytic | 0.452 0.03 CID_6453558 | CID_6453558 | |
| 0.242 | 0.074 | 0.848 | Angiogenesis stimulant | 0.272 0.06 CID_171625 0.848 0.003 CID_6453558 | CID_6453558 | |
| 0.176 | 0.008 | 0.176 | Prostaglandin EP2 antagonist | 0.082 0.025 CID_171625 0.061 0.04 CID_6453558 | ||
| 0.27 | 0.105 | 0.421 | Thyroid hormone beta antagonist | 0.421 0.047 CID_171625 | CID_171625 | |
| 0.204 | 0.039 | 0.382 | NOS3 expression enhancer | 0.382 0.009 CID_6453558 | CID_6453558 | |
| 0.24 | 0.075 | 0.455 | Antiamyloidogenic | 0.174 0.119 CID_171625 0.455 0.021 CID_6453558 | CID_6453558 | |
| 0.197 | 0.034 | 0.431 | Hemostatic | 0.205 0.03 CID_171625 0.431 0.006 CID_6453558 | CID_6453558 | |
| 0.187 | 0.027 | 0.187 | Cathepsin H inhibitor | 0.118 0.078 CID_171625 | ||
| 0.192 | 0.036 | 0.192 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.164 | 0.009 | 0.164 | Prostaglandin antagonist | |||
| 0.159 | 0.005 | 0.159 | D-Ala-D-Ala ligase inhibitor | 0.095 0.036 CID_171625 | ||
| 0.315 | 0.162 | 0.717 | Apoptosis agonist | 0.717 0.028 CID_6453558 | CID_6453558 | |
| 0.165 | 0.015 | 0.165 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.201 | 0.051 | 0.379 | Thrombolytic | 0.251 0.033 CID_171625 0.379 0.013 CID_6453558 | CID_6453558 | |
| 0.171 | 0.021 | 0.214 | Photosensitizer | 0.121 0.055 CID_171625 0.214 0.01 CID_6453558 | CID_6453558 | |
| 0.165 | 0.016 | 0.466 | Selectin antagonist | 0.148 0.018 CID_171625 0.466 0.003 CID_6453558 | CID_6453558 | |
| 0.193 | 0.044 | 0.286 | ATPase inhibitor | 0.172 0.068 CID_171625 0.286 0.008 CID_6453558 | CID_6453558 | |
| 0.152 | 0.004 | 0.152 | Glutamate (mGluR3) antagonist | |||
| 0.153 | 0.005 | 0.153 | Peroxisome proliferator-activated receptor gamma antagonist | 0.132 0.008 CID_171625 | ||
| 0.181 | 0.035 | 0.181 | CF transmembrane conductance regulator agonist | 0.167 0.051 CID_171625 0.179 0.037 CID_6453558 | ||
| 0.161 | 0.016 | 0.161 | Electron transport complex I inhibitor | 0.154 0.018 CID_171625 | ||
| 0.152 | 0.008 | 0.152 | NMDA receptor agonist | 0.114 0.015 CID_171625 | ||
| 0.155 | 0.012 | 0.155 | Aminopeptidase I inhibitor | 0.134 0.016 CID_171625 | ||
| 0.174 | 0.03 | 0.174 | 5-Lipoxygenase inhibitor | |||
| 0.149 | 0.006 | 0.239 | CD45 antagonist | 0.239 0.004 CID_171625 | CID_171625 | |
| 0.15 | 0.007 | 0.173 | Neuraminidase (influenza) inhibitor | 0.173 0.005 CID_6453558 | CID_6453558 | |
| 0.186 | 0.044 | 0.186 | Neurotensin receptor agonist | 0.184 0.046 CID_171625 | ||
| 0.171 | 0.034 | 0.171 | Adenylate cyclase stimulant | 0.17 0.035 CID_171625 0.161 0.046 CID_6453558 | ||
| 0.179 | 0.043 | 0.179 | Alkaline phosphatase inhibitor | 0.137 0.069 CID_171625 0.164 0.051 CID_6453558 | ||
| 0.204 | 0.067 | 0.204 | I kappa B kinase epsilon inhibitor | |||
| 0.238 | 0.101 | 0.558 | Immunostimulant | 0.31 0.076 CID_171625 0.558 0.022 CID_6453558 | CID_6453558 | |
| 0.141 | 0.005 | 0.141 | Peroxisome proliferator-activated receptor delta antagonist | 0.05 0.009 CID_171625 | ||
| 0.147 | 0.01 | 0.147 | Leukotriene antagonist | 0.079 0.033 CID_171625 0.077 0.034 CID_6453558 | ||
| 0.177 | 0.042 | 0.177 | NADPH oxidase inhibitor | |||
| 0.141 | 0.007 | 0.141 | Peroxisome proliferator-activated receptor alpha agonist | 0.097 0.013 CID_171625 | ||
| 0.146 | 0.012 | 0.146 | Purinergic P2X2 antagonist | 0.072 0.044 CID_171625 | ||
| 0.137 | 0.003 | 0.137 | Retinoid X alpha receptor agonist | |||
| 0.136 | 0.003 | 0.136 | Dihydroorotate oxidase inhibitor | 0.053 0.044 CID_171625 | ||
| 0.147 | 0.014 | 0.147 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.05 CID_171625 0.071 0.038 CID_6453558 | ||
| 0.141 | 0.008 | 0.141 | Glycine receptor agonist | 0.078 0.041 CID_171625 0.093 0.025 CID_6453558 | ||
| 0.136 | 0.004 | 0.136 | Glutamate (mGluR group III) antagonist | |||
| 0.15 | 0.018 | 0.15 | Anabolic | 0.11 0.05 CID_171625 0.109 0.051 CID_6453558 | ||
| 0.136 | 0.005 | 0.136 | GABA B receptor agonist | 0.097 0.019 CID_171625 | ||
| 0.154 | 0.023 | 0.632 | Beta glucuronidase inhibitor | 0.632 0.003 CID_6453558 | CID_6453558 | |
| 0.157 | 0.027 | 0.157 | Protein kinase C gamma inhibitor | 0.129 0.045 CID_6453558 | ||
| 0.197 | 0.067 | 0.61 | Hepatoprotectant | 0.185 0.075 CID_171625 0.61 0.004 CID_6453558 | CID_6453558 | |
| 0.135 | 0.005 | 0.135 | NMDA receptor glycine site agonist | 0.107 0.013 CID_171625 | ||
| 0.158 | 0.029 | 0.158 | Interleukin 8 antagonist | 0.102 0.092 CID_171625 | ||
| 0.133 | 0.004 | 0.133 | Glutamate (mGluR4) antagonist | 0.041 0.035 CID_171625 | ||
| 0.133 | 0.004 | 0.133 | Glutamate (mGluR7) antagonist | 0.073 0.038 CID_171625 | ||
| 0.165 | 0.038 | 0.169 | Interleukin 4 antagonist | 0.169 0.035 CID_6453558 | CID_6453558 | |
| 0.16 | 0.033 | 0.251 | Microtubule formation inhibitor | 0.127 0.053 CID_171625 0.251 0.009 CID_6453558 | CID_6453558 | |
| 0.129 | 0.002 | 0.129 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.165 | 0.039 | 0.165 | Nav1.6 sodium channel blocker | |||
| 0.179 | 0.054 | 0.179 | Diuretic | 0.179 0.054 CID_171625 0.157 0.072 CID_6453558 | ||
| 0.129 | 0.004 | 0.129 | Dihydroorotase inhibitor | |||
| 0.13 | 0.007 | 0.179 | Estrogen-related receptor beta agonist | 0.179 0.003 CID_171625 | CID_171625 | |
| 0.164 | 0.042 | 0.252 | DNA polymerase I inhibitor | 0.105 0.081 CID_171625 0.252 0.017 CID_6453558 | CID_6453558 | |
| 0.13 | 0.008 | 0.13 | Neuraminidase inhibitor | 0.126 0.009 CID_6453558 | ||
| 0.139 | 0.017 | 0.139 | Carbonic anhydrase V inhibitor | 0.062 0.051 CID_171625 | ||
| 0.126 | 0.004 | 0.126 | RNA-directed RNA polymerase inhibitor | 0.078 0.007 CID_171625 | ||
| 0.13 | 0.009 | 0.246 | Phosphorylase inhibitor | 0.205 0.005 CID_171625 0.246 0.004 CID_6453558 | CID_6453558 | |
| 0.194 | 0.073 | 0.194 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.127 | 0.006 | 0.127 | Leukotriene B4 antagonist | 0.106 0.009 CID_6453558 | ||
| 0.131 | 0.01 | 0.131 | Granulocyte macrophage colony stimulating factor agonist | 0.111 0.022 CID_171625 | ||
| 0.125 | 0.004 | 0.125 | Nicotinic acid receptor agonist | |||
| 0.12 | 0.004 | 0.12 | Lysophosphatidic acid 3 receptor antagonist | 0.074 0.012 CID_171625 | ||
| 0.12 | 0.004 | 0.12 | Purinergic P2Y14 antagonist | |||
| 0.137 | 0.021 | 0.137 | Glutamate receptor agonist | |||
| 0.136 | 0.023 | 0.136 | MAP kinase kinase 1 inhibitor | |||
| 0.121 | 0.007 | 0.121 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.12 | 0.007 | 0.12 | Prostaglandin F2 alpha antagonist | 0.062 0.044 CID_171625 | ||
| 0.118 | 0.005 | 0.118 | TRPM8 blocker | |||
| 0.117 | 0.005 | 0.117 | Nicotinic acid receptor 2 agonist | |||
| 0.116 | 0.004 | 0.116 | Retinoic acid alpha receptor agonist | |||
| 0.116 | 0.004 | 0.116 | Adenine nucleotide translocase inhibitor | 0.062 0.025 CID_171625 0.099 0.005 CID_6453558 | ||
| 0.134 | 0.024 | 0.134 | Cathepsin G inhibitor | 0.13 0.025 CID_171625 | ||
| 0.114 | 0.004 | 0.114 | HCV NS5B polymerase inhibitor | 0.057 0.009 CID_171625 | ||
| 0.126 | 0.016 | 0.126 | Carbonic anhydrase VA inhibitor | 0.067 0.05 CID_171625 | ||
| 0.13 | 0.021 | 0.13 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.137 | 0.028 | 0.137 | Prolactin inhibitor | 0.096 0.059 CID_171625 | ||
| 0.116 | 0.009 | 0.116 | 5-Alpha-reductase inhibitor | 0.034 0.029 CID_171625 | ||
| 0.115 | 0.007 | 0.115 | Oleamide hydrolase inhibitor | 0.054 0.024 CID_171625 | ||
| 0.123 | 0.016 | 0.123 | HIV-1 integrase (Strand Transfer) inhibitor | 0.058 0.043 CID_6453558 | ||
| 0.206 | 0.099 | 0.206 | Aryl hydrocarbon receptor agonist | |||
| 0.119 | 0.013 | 0.119 | Carbonic anhydrase VB inhibitor | |||
| 0.278 | 0.172 | 0.725 | Alpha-glucosidase inhibitor | 0.725 0.029 CID_6453558 | CID_6453558 | |
| 0.114 | 0.008 | 0.144 | Carbonic anhydrase XIV inhibitor | 0.066 0.022 CID_171625 0.144 0.005 CID_6453558 | CID_6453558 | |
| 0.109 | 0.004 | 0.109 | Retinoid X receptor agonist | |||
| 0.14 | 0.036 | 0.148 | Caspase 3 inhibitor | 0.148 0.029 CID_171625 | CID_171625 | |
| 0.124 | 0.02 | 0.158 | Glutamate release inhibitor | 0.158 0.008 CID_6453558 | CID_6453558 | |
| 0.14 | 0.037 | 0.14 | Protein kinase (CK2) inhibitor | |||
| 0.142 | 0.039 | 0.215 | DNA repair enzyme inhibitor | 0.215 0.007 CID_6453558 | CID_6453558 | |
| 0.146 | 0.044 | 0.146 | Protein kinase (CK2) alpha inhibitor | |||
| 0.208 | 0.106 | 0.238 | Calpain inhibitor | 0.238 0.077 CID_171625 | CID_171625 | |
| 0.132 | 0.03 | 0.132 | NMDA receptor antagonist | |||
| 0.148 | 0.047 | 0.191 | Adenylate cyclase inhibitor | 0.191 0.027 CID_171625 0.102 0.082 CID_6453558 | CID_171625 | |
| 0.122 | 0.021 | 0.155 | Glutathione S-transferase inhibitor | 0.155 0.011 CID_171625 | CID_171625 | |
| 0.134 | 0.032 | 0.134 | Sphingomyelinase inhibitor | 0.123 0.039 CID_171625 0.129 0.035 CID_6453558 | ||
| 0.149 | 0.049 | 0.149 | Anesthetic local | |||
| 0.11 | 0.01 | 0.11 | NMDA receptor subunit 3B antagonist | 0.04 0.034 CID_171625 | ||
| 0.189 | 0.09 | 0.244 | Platelet aggregation inhibitor | 0.244 0.054 CID_171625 | CID_171625 | |
| 0.103 | 0.004 | 0.103 | Prostaglandin EP4 antagonist | 0.032 0.014 CID_171625 | ||
| 0.102 | 0.003 | 0.102 | Free fatty acid receptor 1 antagonist | 0.047 0.01 CID_171625 | ||
| 0.101 | 0.003 | 0.101 | Retinoid X beta receptor agonist | |||
| 0.101 | 0.004 | 0.101 | Retinoic acid receptor agonist | |||
| 0.11 | 0.014 | 0.11 | Collagenase 3 inhibitor | 0.094 0.018 CID_171625 | ||
| 0.11 | 0.014 | 0.11 | Ornithine carbamoyltransferase inhibitor | 0.068 0.027 CID_171625 | ||
| 0.1 | 0.004 | 0.1 | Farnesoid X receptor agonist | 0.036 0.028 CID_171625 | ||
| 0.111 | 0.016 | 0.12 | Sphingosine 1-phosphate receptor antagonist | 0.12 0.013 CID_171625 | CID_171625 | |
| 0.145 | 0.05 | 0.351 | Cell adhesion inhibitor | 0.2 0.025 CID_171625 0.351 0.007 CID_6453558 | CID_6453558 | |
| 0.158 | 0.063 | 0.421 | Lipid peroxidase inhibitor | 0.125 0.089 CID_171625 0.421 0.009 CID_6453558 | CID_6453558 | |
| 0.1 | 0.005 | 0.1 | 5-Alpha-reductase 2 inhibitor | |||
| 0.142 | 0.047 | 0.16 | Vanilloid 1 agonist | 0.16 0.029 CID_171625 0.142 0.047 CID_6453558 | CID_171625 | |
| 0.104 | 0.01 | 0.104 | Thromboxane antagonist | 0.065 0.029 CID_171625 | ||
| 0.156 | 0.063 | 0.156 | Thiol protease inhibitor | 0.147 0.072 CID_171625 | ||
| 0.096 | 0.004 | 0.096 | Retinoid X gamma receptor agonist | |||
| 0.152 | 0.06 | 0.152 | Cytokine production inhibitor | |||
| 0.112 | 0.02 | 0.112 | Leukotriene synthesis inhibitor | |||
| 0.118 | 0.026 | 0.118 | Adrenaline agonist | 0.089 0.046 CID_171625 | ||
| 0.229 | 0.138 | 0.229 | Prostaglandin dehydrogenase inhibitor | |||
| 0.128 | 0.037 | 0.128 | Urease inhibitor | 0.119 0.046 CID_171625 | ||
| 0.159 | 0.069 | 0.159 | Cytidine deaminase inhibitor | |||
| 0.095 | 0.005 | 0.095 | Urate transporter 1 inhibitor | |||
| 0.094 | 0.004 | 0.094 | NMDA 2D receptor antagonist | |||
| 0.094 | 0.005 | 0.094 | Peroxisome proliferator-activated receptor alpha antagonist | 0.019 0.016 CID_171625 | ||
| 0.092 | 0.003 | 0.092 | Uridine phosphorylase inhibitor | 0.041 0.011 CID_171625 0.083 0.003 CID_6453558 | ||
| 0.1 | 0.01 | 0.1 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.095 | 0.006 | 0.095 | Fumarate hydratase inhibitor | 0.033 0.025 CID_171625 0.034 0.024 CID_6453558 | ||
| 0.11 | 0.021 | 0.16 | Sphingosine 1-phosphate receptor 4 agonist | 0.16 0.007 CID_171625 | CID_171625 | |
| 0.116 | 0.027 | 0.263 | Transcription factor NF kappa B stimulant | 0.263 0.005 CID_6453558 | CID_6453558 | |
| 0.112 | 0.023 | 0.157 | Glycine receptor antagonist | 0.084 0.05 CID_171625 0.157 0.006 CID_6453558 | CID_6453558 | |
| 0.093 | 0.005 | 0.093 | Leukotriene C antagonist | 0.074 0.011 CID_171625 | ||
| 0.137 | 0.049 | 0.137 | Interleukin 1b antagonist | 0.111 0.07 CID_6453558 | ||
| 0.091 | 0.004 | 0.091 | Prostaglandin EP4 agonist | |||
| 0.108 | 0.02 | 0.108 | Potassium channel large-conductance Ca-activated activator | |||
| 0.118 | 0.032 | 0.123 | Glutamate (mGluR7) agonist | 0.123 0.028 CID_171625 | CID_171625 | |
| 0.105 | 0.019 | 0.105 | Carbamoyl phosphate synthetase inhibitor | 0.076 0.031 CID_171625 0.058 0.045 CID_6453558 | ||
| 0.164 | 0.079 | 0.164 | Antipruritic | |||
| 0.119 | 0.036 | 0.172 | Interleukin 1 beta converting enzyme inhibitor | 0.172 0.01 CID_171625 | CID_171625 | |
| 0.093 | 0.009 | 0.093 | Thromboxane A2 antagonist | 0.061 0.027 CID_171625 | ||
| 0.089 | 0.006 | 0.089 | Prostaglandin agonist | |||
| 0.093 | 0.01 | 0.093 | Sphingosine 1-phosphate receptor 3 antagonist | 0.079 0.017 CID_171625 | ||
| 0.092 | 0.009 | 0.092 | Heme oxygenase stimulant | 0.07 0.025 CID_171625 0.058 0.054 CID_6453558 | ||
| 0.116 | 0.033 | 0.116 | Histamine N-methyltransferase inhibitor | |||
| 0.087 | 0.004 | 0.087 | GABA uptake inhibitor | |||
| 0.086 | 0.004 | 0.086 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.087 | 0.005 | 0.235 | Heparanase inhibitor | 0.074 0.009 CID_171625 0.235 0.002 CID_6453558 | CID_6453558 | |
| 0.086 | 0.004 | 0.086 | Glutamate (mGluR8) agonist | 0.037 0.028 CID_171625 | ||
| 0.105 | 0.024 | 0.105 | Prostaglandin-E synthase inhibitor | 0.067 0.052 CID_171625 | ||
| 0.128 | 0.047 | 0.305 | Chelator | 0.305 0.01 CID_171625 | CID_171625 | |
| 0.083 | 0.003 | 0.083 | Lysophosphatidic acid 1 receptor antagonist | 0.029 0.007 CID_171625 | ||
| 0.086 | 0.006 | 0.086 | Liver X receptor alpha agonist | 0.038 0.034 CID_171625 | ||
| 0.083 | 0.003 | 0.083 | Retinoic acid beta receptor agonist | |||
| 0.09 | 0.011 | 0.09 | MDM2 inhibitor | |||
| 0.081 | 0.003 | 0.081 | Retinoic acid beta receptor antagonist | |||
| 0.08 | 0.003 | 0.08 | Retinoic acid alpha receptor antagonist | |||
| 0.262 | 0.185 | 0.262 | DNA polymerase beta inhibitor | |||
| 0.082 | 0.006 | 0.082 | Pregnane X receptor antagonist | |||
| 0.095 | 0.018 | 0.095 | MAP kinase kinase 7 inhibitor | 0.076 0.06 CID_171625 | ||
| 0.09 | 0.015 | 0.09 | Autotaxin inhibitor | |||
| 0.11 | 0.035 | 0.163 | Phosphodiesterase 6D inhibitor | 0.163 0.007 CID_6453558 | CID_6453558 | |
| 0.09 | 0.015 | 0.09 | Exportin-1 inhibitor | 0.069 0.046 CID_171625 | ||
| 0.161 | 0.086 | 0.577 | Nitric oxide antagonist | 0.577 0.011 CID_6453558 | CID_6453558 | |
| 0.121 | 0.046 | 0.132 | Acetylcholine release stimulant | 0.132 0.031 CID_6453558 | CID_6453558 | |
| 0.099 | 0.025 | 0.104 | Amidase inhibitor | 0.104 0.022 CID_171625 | CID_171625 | |
| 0.161 | 0.087 | 0.161 | Tumour necrosis factor antagonist | |||
| 0.111 | 0.038 | 0.135 | Thioredoxin inhibitor | 0.135 0.022 CID_6453558 | CID_6453558 | |
| 0.133 | 0.06 | 0.149 | CC chemokine 6 receptor antagonist | 0.149 0.024 CID_6453558 | CID_6453558 | |
| 0.082 | 0.009 | 0.103 | Squalene epoxidase inhibitor | 0.103 0.005 CID_6453558 | CID_6453558 | |
| 0.091 | 0.019 | 0.091 | NMDA 2C receptor antagonist | 0.067 0.036 CID_171625 | ||
| 0.083 | 0.011 | 0.083 | NMDA receptor subunit 3A antagonist | |||
| 0.166 | 0.094 | 0.228 | P-glycoprotein inhibitor | 0.228 0.049 CID_6453558 | CID_6453558 | |
| 0.081 | 0.009 | 0.081 | Ryanodine receptor antagonist | 0.059 0.039 CID_171625 | ||
| 0.075 | 0.003 | 0.075 | Retinoic acid receptor antagonist | |||
| 0.076 | 0.004 | 0.076 | Liver X receptor beta antagonist | 0.032 0.018 CID_171625 | ||
| 0.083 | 0.012 | 0.083 | Topoisomerase II beta inhibitor | 0.058 0.024 CID_171625 | ||
| 0.078 | 0.008 | 0.078 | Peroxisome proliferator-activated receptor delta agonist | 0.048 0.013 CID_171625 | ||
| 0.075 | 0.005 | 0.075 | Prostaglandin EP1 antagonist | |||
| 0.074 | 0.004 | 0.074 | Guanylate cyclase inhibitor | 0.065 0.008 CID_6453558 | ||
| 0.101 | 0.031 | 0.101 | NMDA 2 receptor antagonist | |||
| 0.073 | 0.003 | 0.073 | Glutamate (mGluR3) agonist | 0.037 0.014 CID_171625 | ||
| 0.078 | 0.009 | 0.116 | Glucose-6-phosphate isomerase inhibitor | 0.056 0.022 CID_171625 0.116 0.004 CID_6453558 | CID_6453558 | |
| 0.137 | 0.069 | 0.137 | Interleukin 1 antagonist | |||
| 0.089 | 0.021 | 0.089 | Maillard reaction inhibitor | |||
| 0.07 | 0.003 | 0.07 | Retinoic acid receptor gamma antagonist | |||
| 0.082 | 0.015 | 0.119 | Factor IXa inhibitor | 0.046 0.044 CID_171625 0.119 0.006 CID_6453558 | CID_6453558 | |
| 0.073 | 0.006 | 0.074 | Neuraminidase (Influenza A) inhibitor | 0.074 0.006 CID_6453558 | CID_6453558 | |
| 0.071 | 0.005 | 0.071 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.021 CID_171625 | ||
| 0.134 | 0.068 | 0.172 | Nav1.2 sodium channel blocker | 0.172 0.046 CID_171625 | CID_171625 | |
| 0.12 | 0.054 | 0.122 | Falcipain 3 inhibitor | 0.122 0.052 CID_171625 | CID_171625 | |
| 0.13 | 0.065 | 0.13 | MAP kinase kinase inhibitor | |||
| 0.1 | 0.035 | 0.239 | Cell adhesion molecule inhibitor | 0.138 0.018 CID_171625 0.239 0.007 CID_6453558 | CID_6453558 | |
| 0.072 | 0.007 | 0.072 | Liver X receptor beta agonist | |||
| 0.094 | 0.029 | 0.094 | HIV-1 integrase inhibitor | 0.078 0.039 CID_171625 | ||
| 0.127 | 0.062 | 0.278 | Alkylator | 0.149 0.047 CID_171625 0.278 0.014 CID_6453558 | CID_6453558 | |
| 0.073 | 0.009 | 0.073 | Factor III inhibitor | 0.061 0.017 CID_171625 0.055 0.025 CID_6453558 | ||
| 0.074 | 0.01 | 0.187 | Mannosidase inhibitor | 0.069 0.012 CID_171625 0.187 0.003 CID_6453558 | CID_6453558 | |
| 0.086 | 0.023 | 0.086 | CDC25B inhibitor | |||
| 0.067 | 0.005 | 0.067 | Leukotriene C4 antagonist | 0.049 0.011 CID_171625 | ||
| 0.106 | 0.043 | 0.106 | Calcium antagonist | |||
| 0.119 | 0.057 | 0.119 | Estrogen antagonist | |||
| 0.072 | 0.01 | 0.072 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.194 | 0.131 | 0.194 | Neuropeptide Y2 antagonist | |||
| 0.229 | 0.167 | 0.528 | Immunosuppressant | 0.528 0.026 CID_6453558 | CID_6453558 | |
| 0.149 | 0.087 | 0.149 | Heat shock protein 90 alpha antagonist | |||
| 0.066 | 0.005 | 0.066 | Prostaglandin E2 agonist | |||
| 0.065 | 0.005 | 0.065 | Retinoid X receptor antagonist | |||
| 0.069 | 0.009 | 0.069 | Dihydropteroate synthase inhibitor | 0.05 0.017 CID_171625 | ||
| 0.183 | 0.123 | 0.401 | Peptidyltransferase inhibitor | 0.31 0.021 CID_171625 0.401 0.007 CID_6453558 | CID_6453558 | |
| 0.093 | 0.033 | 0.093 | Estrogen receptor alpha antagonist | |||
| 0.064 | 0.005 | 0.064 | ATP citrate lysase inhibitor | |||
| 0.074 | 0.015 | 0.074 | Thromboxane synthase inhibitor | 0.065 0.022 CID_171625 | ||
| 0.071 | 0.012 | 0.071 | Kainate receptor antagonist | |||
| 0.126 | 0.067 | 0.126 | Nav1.3 sodium channel blocker | 0.124 0.07 CID_171625 | ||
| 0.063 | 0.004 | 0.063 | CF transmembrane conductance regulator antagonist | |||
| 0.078 | 0.019 | 0.078 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.063 | 0.005 | 0.063 | Kainate receptor agonist | 0.041 0.029 CID_171625 | ||
| 0.066 | 0.009 | 0.066 | Dopamine D5 agonist | 0.04 0.027 CID_171625 | ||
| 0.068 | 0.011 | 0.068 | Cholesterol esterase inhibitor | 0.064 0.014 CID_6453558 | ||
| 0.096 | 0.04 | 0.096 | Myeloperoxidase inhibitor | |||
| 0.128 | 0.072 | 0.128 | Cyclooxygenase 1 inhibitor | 0.122 0.078 CID_6453558 | ||
| 0.068 | 0.012 | 0.068 | Sphingosine 1-phosphate receptor agonist | 0.062 0.015 CID_171625 | ||
| 0.082 | 0.027 | 0.086 | Protein kinase C beta inhibitor | 0.086 0.023 CID_6453558 | CID_6453558 | |
| 0.071 | 0.016 | 0.168 | Alpha-mannosidase inhibitor | 0.081 0.011 CID_171625 0.168 0.004 CID_6453558 | CID_6453558 | |
| 0.108 | 0.053 | 0.108 | Factor V inhibitor | |||
| 0.061 | 0.006 | 0.061 | 5-Alpha-reductase 1 inhibitor | |||
| 0.077 | 0.022 | 0.103 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.103 0.014 CID_6453558 | CID_6453558 | |
| 0.073 | 0.018 | 0.086 | Diacylglycerol O-acyltransferase inhibitor | 0.086 0.011 CID_171625 | CID_171625 | |
| 0.089 | 0.034 | 0.119 | Epoxide hydrolase inhibitor | 0.119 0.018 CID_171625 | CID_171625 | |
| 0.058 | 0.005 | 0.058 | Cholesterol ester transfer protein antagonist | |||
| 0.062 | 0.008 | 0.062 | Nerve growth factor antagonist | |||
| 0.058 | 0.004 | 0.095 | Tryptophan 5 hydroxylase inhibitor | 0.095 0.002 CID_171625 | CID_171625 | |
| 0.076 | 0.022 | 0.076 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.069 0.029 CID_171625 | ||
| 0.058 | 0.005 | 0.058 | Glutamate (mGluR8) antagonist | 0.034 0.028 CID_171625 | ||
| 0.246 | 0.194 | 0.246 | DNA directed DNA polymerase inhibitor | |||
| 0.056 | 0.004 | 0.056 | Retinoid X alpha receptor antagonist | |||
| 0.108 | 0.057 | 0.198 | Toll-Like receptor 4 antagonist | 0.198 0.006 CID_6453558 | CID_6453558 | |
| 0.058 | 0.007 | 0.058 | Lysophosphatidic acid 2 receptor antagonist | 0.034 0.017 CID_171625 | ||
| 0.076 | 0.027 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.064 0.045 CID_171625 | ||
| 0.053 | 0.004 | 0.053 | Nicotinic acid receptor 2 antagonist | |||
| 0.067 | 0.018 | 0.075 | Sphingosine 1-phosphate receptor 5 agonist | 0.075 0.014 CID_171625 | CID_171625 | |
| 0.061 | 0.012 | 0.061 | Glutamate (mGluR group II) agonist | |||
| 0.065 | 0.017 | 0.065 | Adenosine deaminase inhibitor | 0.054 0.026 CID_6453558 | ||
| 0.067 | 0.018 | 0.114 | Glucose-6-phosphate translocase inhibitor | 0.114 0.005 CID_6453558 | CID_6453558 | |
| 0.065 | 0.016 | 0.065 | Leukocyte elastase inhibitor | 0.052 0.023 CID_171625 | ||
| 0.129 | 0.082 | 0.129 | Neurotrophic factor | |||
| 0.072 | 0.024 | 0.072 | Calcium channel P-type blocker | |||
| 0.056 | 0.01 | 0.056 | Angiotensin AT1 receptor antagonist | |||
| 0.096 | 0.05 | 0.096 | Androgen antagonist | |||
| 0.052 | 0.006 | 0.052 | Leukotriene B4 receptor 1 antagonist | |||
| 0.067 | 0.021 | 0.075 | Sphingosine 1-phosphate receptor 1 antagonist | 0.075 0.016 CID_171625 | CID_171625 | |
| 0.051 | 0.005 | 0.051 | Prostaglandin EP2 agonist | |||
| 0.059 | 0.014 | 0.059 | Guanylate cyclase stimulant | |||
| 0.078 | 0.033 | 0.078 | Bcl2 antagonist | |||
| 0.072 | 0.027 | 0.154 | Protein kinase C eta inhibitor | 0.154 0.007 CID_6453558 | CID_6453558 | |
| 0.094 | 0.049 | 0.094 | Interleukin 5 antagonist | |||
| 0.051 | 0.008 | 0.051 | Carnitine palmitoyltransferase inhibitor | |||
| 0.065 | 0.021 | 0.085 | DNA helicase inhibitor | 0.085 0.009 CID_171625 | CID_171625 | |
| 0.059 | 0.016 | 0.059 | Dopamine beta hydroxylase inhibitor | |||
| 0.047 | 0.004 | 0.047 | Retinoic acid gamma receptor agonist | |||
| 0.122 | 0.079 | 0.122 | Antibacterial (Helicobacter pylori) | |||
| 0.05 | 0.007 | 0.05 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.05 | 0.008 | 0.05 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.056 | 0.013 | 0.056 | Kainate receptor 2 antagonist | |||
| 0.057 | 0.015 | 0.057 | Sphingosine 1-phosphate receptor 1 agonist | 0.053 0.017 CID_171625 | ||
| 0.185 | 0.143 | 0.185 | Streptokinase A inhibitor | |||
| 0.067 | 0.025 | 0.07 | Beta 2 adrenoreceptor agonist | 0.07 0.02 CID_171625 | CID_171625 | |
| 0.057 | 0.016 | 0.057 | Geranyltranstransferase inhibitor | |||
| 0.067 | 0.026 | 0.068 | NMDA 2A receptor antagonist | 0.068 0.025 CID_171625 | CID_171625 | |
| 0.046 | 0.005 | 0.071 | Thyroid hormone agonist | 0.071 0.003 CID_171625 | CID_171625 | |
| 0.087 | 0.046 | 0.14 | Metalloproteinase-2 inhibitor | 0.14 0.022 CID_171625 | CID_171625 | |
| 0.053 | 0.013 | 0.053 | Glutamate (mGluR2) agonist | |||
| 0.053 | 0.013 | 0.053 | Beta adrenoreceptor agonist | 0.048 0.023 CID_171625 | ||
| 0.044 | 0.004 | 0.047 | Vanilloid 2 agonist | 0.047 0.003 CID_6453558 | CID_6453558 | |
| 0.045 | 0.004 | 0.045 | Prostaglandin H2 antagonist | 0.027 0.016 CID_171625 | ||
| 0.078 | 0.038 | 0.136 | Phospholipase D inhibitor | 0.136 0.004 CID_171625 | CID_171625 | |
| 0.079 | 0.039 | 0.079 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.058 | 0.019 | 0.058 | Glutamate (mGluR group III) agonist | |||
| 0.052 | 0.014 | 0.07 | Squalene synthetase inhibitor | 0.07 0.009 CID_6453558 | CID_6453558 | |
| 0.148 | 0.11 | 0.199 | Amyloid beta aggregation inhibitor | 0.144 0.112 CID_171625 0.199 0.078 CID_6453558 | CID_6453558 | |
| 0.167 | 0.128 | 0.374 | Platelet antagonist | 0.267 0.065 CID_171625 0.374 0.033 CID_6453558 | CID_6453558 | |
| 0.052 | 0.014 | 0.052 | Glutamate (mGluR group II) antagonist | |||
| 0.101 | 0.063 | 0.101 | Estrogen receptor beta antagonist | |||
| 0.101 | 0.064 | 0.101 | Check point kinase 2 inhibitor | |||
| 0.079 | 0.042 | 0.08 | Vanilloid 4 agonist | 0.08 0.04 CID_171625 | CID_171625 | |
| 0.042 | 0.005 | 0.042 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 CID_6453558 | ||
| 0.112 | 0.075 | 0.23 | Topoisomerase II inhibitor | 0.23 0.028 CID_6453558 | CID_6453558 | |
| 0.132 | 0.095 | 0.132 | Neuropeptide Y1 antagonist | |||
| 0.042 | 0.005 | 0.042 | Glutamate (mGluR1) agonist | 0.024 0.019 CID_171625 | ||
| 0.041 | 0.004 | 0.041 | Thyroid hormone alpha antagonist | 0.036 0.005 CID_171625 | ||
| 0.042 | 0.005 | 0.042 | Glutamate (mGluR1a) agonist | 0.027 0.011 CID_171625 | ||
| 0.04 | 0.004 | 0.107 | Egl nine homolog 1 inhibitor | 0.107 0.002 CID_171625 | CID_171625 | |
| 0.043 | 0.007 | 0.043 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.045 | 0.009 | 0.045 | Angiotensin II receptor antagonist | |||
| 0.043 | 0.007 | 0.043 | Calcium-sensing receptor agonist | 0.042 0.007 CID_171625 | ||
| 0.055 | 0.019 | 0.055 | Liver X receptor agonist | |||
| 0.057 | 0.022 | 0.057 | Sodium/calcium exchanger inhibitor | 0.055 0.025 CID_171625 | ||
| 0.077 | 0.043 | 0.077 | Calcium channel L-type blocker | |||
| 0.042 | 0.008 | 0.042 | NMDA receptor glycine site antagonist | |||
| 0.043 | 0.009 | 0.043 | Epoxide hydrolase 1 inhibitor | 0.035 0.015 CID_171625 | ||
| 0.15 | 0.116 | 0.173 | Psychostimulant | 0.173 0.098 CID_6453558 | CID_6453558 | |
| 0.061 | 0.027 | 0.092 | Epithelial sodium channel blocker | 0.092 0.009 CID_171625 | CID_171625 | |
| 0.039 | 0.005 | 0.039 | Retinoid X gamma receptor antagonist | |||
| 0.054 | 0.02 | 0.054 | Benzodiazepine antagonist | |||
| 0.088 | 0.054 | 0.088 | Phosphodiesterase IV inhibitor | |||
| 0.043 | 0.01 | 0.043 | Protein kinase (CK2) beta inhibitor | |||
| 0.053 | 0.02 | 0.059 | AICAR transformylase inhibitor | 0.059 0.015 CID_171625 | CID_171625 | |
| 0.047 | 0.014 | 0.047 | Somatostatin 5 antagonist | |||
| 0.04 | 0.007 | 0.04 | Kainate receptor 1 antagonist | |||
| 0.037 | 0.005 | 0.071 | ICAM 1 antagonist | 0.071 0.003 CID_171625 | CID_171625 | |
| 0.055 | 0.022 | 0.055 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.036 | 0.004 | 0.036 | Neuraminidase (Influenza B) inhibitor | |||
| 0.048 | 0.016 | 0.052 | Arginase inhibitor | 0.033 0.029 CID_171625 0.052 0.014 CID_6453558 | CID_6453558 | |
| 0.035 | 0.004 | 0.035 | Retinoid X beta receptor antagonist | |||
| 0.037 | 0.005 | 0.037 | Beta 1 adrenoreceptor agonist | 0.021 0.019 CID_171625 | ||
| 0.069 | 0.038 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.036 CID_171625 | CID_171625 | |
| 0.045 | 0.015 | 0.045 | Estrogen-related receptor alpha antagonist | |||
| 0.05 | 0.02 | 0.05 | Nicotinic acid receptor 1 agonist | |||
| 0.045 | 0.015 | 0.047 | Prostacyclin antagonist | 0.047 0.014 CID_171625 | CID_171625 | |
| 0.118 | 0.088 | 0.162 | Bone formation stimulant | 0.162 0.05 CID_171625 0.116 0.089 CID_6453558 | CID_171625 | |
| 0.058 | 0.028 | 0.058 | Immunoglobulin Fc receptor antagonist | |||
| 0.038 | 0.008 | 0.386 | Protocollagen prolyl hydroxylase inhibitor | 0.386 0.002 CID_171625 | CID_171625 | |
| 0.033 | 0.004 | 0.033 | Nicotinic acid receptor 1 antagonist | |||
| 0.069 | 0.04 | 0.08 | Beta adrenoreceptor antagonist | 0.08 0.027 CID_171625 | CID_171625 | |
| 0.218 | 0.189 | 0.279 | Antiobesity | 0.226 0.18 CID_171625 0.279 0.132 CID_6453558 | CID_6453558 | |
| 0.036 | 0.007 | 0.036 | Estrogen-related receptor gamma antagonist | |||
| 0.038 | 0.01 | 0.038 | Liver X receptor alpha antagonist | |||
| 0.033 | 0.005 | 0.033 | G-protein-coupled receptor 120 agonist | |||
| 0.041 | 0.013 | 0.041 | Melatonin receptor 1A agonist | 0.033 0.024 CID_171625 | ||
| 0.045 | 0.016 | 0.045 | Phosphoglycerate kinase inhibitor | |||
| 0.053 | 0.025 | 0.053 | Carbonic anhydrase VII inhibitor | 0.045 0.034 CID_171625 | ||
| 0.075 | 0.048 | 0.108 | Lipase inhibitor | 0.063 0.061 CID_171625 0.108 0.023 CID_6453558 | CID_6453558 | |
| 0.043 | 0.017 | 0.055 | Integrin alpha2 antagonist | 0.055 0.009 CID_171625 | CID_171625 | |
| 0.068 | 0.042 | 0.089 | Neutrophil collagenase inhibitor | 0.089 0.027 CID_171625 | CID_171625 | |
| 0.038 | 0.012 | 0.04 | Protein kinase C beta I inhibitor | 0.04 0.009 CID_6453558 | CID_6453558 | |
| 0.075 | 0.049 | 0.075 | CDC25A inhibitor | |||
| 0.045 | 0.02 | 0.045 | AMPA 4 receptor antagonist | |||
| 0.093 | 0.067 | 0.093 | Lanosterol 14 alpha demethylase inhibitor | 0.089 0.073 CID_171625 | ||
| 0.043 | 0.018 | 0.054 | VCAM-1 antagonist | 0.054 0.007 CID_171625 | CID_171625 | |
| 0.043 | 0.018 | 0.054 | VCAM antagonist | 0.054 0.007 CID_171625 | CID_171625 | |
| 0.045 | 0.02 | 0.055 | Membrane dipeptidase inhibitor | 0.055 0.013 CID_171625 | CID_171625 | |
| 0.039 | 0.014 | 0.039 | Liver X receptor antagonist | |||
| 0.058 | 0.034 | 0.058 | Sphingosine kinase 2 inhibitor | |||
| 0.06 | 0.036 | 0.06 | Fatty acid synthase inhibitor | 0.056 0.04 CID_6453558 | ||
| 0.069 | 0.045 | 0.069 | Acetylcholine M5 receptor agonist | |||
| 0.049 | 0.026 | 0.049 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.124 | 0.101 | 0.126 | Death-associated protein kinase 1 inhibitor | 0.126 0.092 CID_171625 | CID_171625 | |
| 0.027 | 0.005 | 0.027 | Carbonic anhydrase X inhibitor | |||
| 0.027 | 0.005 | 0.027 | Carbonic anhydrase VIII inhibitor | |||
| 0.196 | 0.174 | 0.42 | Angiogenesis inhibitor | 0.42 0.048 CID_6453558 | CID_6453558 | |
| 0.042 | 0.021 | 0.042 | Diamine oxidase inhibitor | |||
| 0.076 | 0.054 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 CID_6453558 | CID_6453558 | |
| 0.053 | 0.032 | 0.057 | Prolyl endopeptidase inhibitor | 0.057 0.028 CID_171625 | CID_171625 | |
| 0.048 | 0.027 | 0.048 | Purinergic P2X4 antagonist | |||
| 0.046 | 0.025 | 0.046 | Dihydrofolate reductase inhibitor | 0.046 0.024 CID_171625 | ||
| 0.033 | 0.012 | 0.04 | LFA antagonist | 0.04 0.008 CID_171625 | CID_171625 | |
| 0.072 | 0.052 | 0.103 | Metalloproteinase-9 inhibitor | 0.103 0.031 CID_171625 | CID_171625 | |
| 0.081 | 0.06 | 0.081 | Thioredoxin reductase inhibitor | |||
| 0.048 | 0.028 | 0.048 | Purinergic P2Y antagonist | |||
| 0.023 | 0.004 | 0.023 | Glutamate (mGluR6) agonist | |||
| 0.088 | 0.069 | 0.088 | Protein kinase C zeta inhibitor | |||
| 0.029 | 0.01 | 0.029 | Prostaglandin F2 alpha agonist | |||
| 0.036 | 0.017 | 0.036 | Prostaglandin EP3 antagonist | |||
| 0.058 | 0.04 | 0.07 | Botulinum neurotoxin type A inhibitor | 0.07 0.025 CID_171625 | CID_171625 | |
| 0.027 | 0.008 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 CID_6453558 | ||
| 0.037 | 0.019 | 0.037 | Purinergic P2Y2 antagonist | |||
| 0.032 | 0.015 | 0.032 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.049 | 0.031 | 0.049 | Aldosterone antagonist | |||
| 0.025 | 0.008 | 0.025 | Free fatty acid receptor 1 agonist | |||
| 0.022 | 0.005 | 0.022 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.028 | 0.012 | 0.028 | Complement factor 1s inhibitor | |||
| 0.019 | 0.004 | 0.04 | Egl nine homolog 3 inhibitor | 0.04 0.003 CID_171625 | CID_171625 | |
| 0.025 | 0.01 | 0.025 | Hexokinase stimulant | |||
| 0.029 | 0.014 | 0.029 | Integrin alpha2beta1 antagonist | 0.025 0.02 CID_171625 | ||
| 0.081 | 0.066 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.054 | 0.039 | 0.06 | Matrix metalloproteinase (membrane-type) inhibitor | 0.06 0.032 CID_171625 | CID_171625 | |
| 0.061 | 0.046 | 0.067 | Trypsin inhibitor | 0.067 0.036 CID_171625 | CID_171625 | |
| 0.106 | 0.091 | 0.106 | Transcription factor STAT6 inhibitor | |||
| 0.028 | 0.014 | 0.028 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.016 | 0.003 | 0.016 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.051 | 0.038 | 0.112 | Aldose reductase inhibitor | 0.084 0.022 CID_171625 0.112 0.015 CID_6453558 | CID_6453558 | |
| 0.019 | 0.006 | 0.019 | Angiotensin AT1B receptor antagonist | |||
| 0.11 | 0.097 | 0.11 | Sodium channel (voltage-gated) blocker | |||
| 0.031 | 0.019 | 0.031 | Glutamate (mGluR2) antagonist | |||
| 0.028 | 0.016 | 0.028 | Leukotriene D4 antagonist | |||
| 0.054 | 0.042 | 0.061 | Beta 1 adrenoreceptor antagonist | 0.061 0.034 CID_171625 | CID_171625 | |
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha agonist | 0.018 0.009 CID_171625 | ||
| 0.034 | 0.023 | 0.034 | Glutamate (mGluR4) agonist | |||
| 0.09 | 0.079 | 0.09 | Nav1.1 sodium channel blocker | |||
| 0.029 | 0.018 | 0.029 | Endothelin receptor antagonist | |||
| 0.042 | 0.031 | 0.042 | Heme oxygenase inhibitor | |||
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.044 | 0.034 | 0.055 | Adenylate cyclase 1 inhibitor | 0.055 0.021 CID_171625 | CID_171625 | |
| 0.135 | 0.125 | 0.532 | Platelet adhesion inhibitor | 0.133 0.127 CID_171625 0.532 0.005 CID_6453558 | CID_6453558 | |
| 0.031 | 0.021 | 0.031 | Prostaglandin D2 agonist | |||
| 0.023 | 0.014 | 0.023 | Geranylgeranyltransferase inhibitor | |||
| 0.015 | 0.006 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.019 0.004 CID_171625 | CID_171625 | |
| 0.013 | 0.004 | 0.032 | Thyroid hormone beta agonist | 0.032 0.003 CID_171625 | CID_171625 | |
| 0.191 | 0.183 | 0.449 | Caspase 3 stimulant | 0.449 0.03 CID_6453558 | CID_6453558 | |
| 0.023 | 0.015 | 0.023 | Bombesin agonist | |||
| 0.014 | 0.007 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 CID_6453558 | ||
| 0.059 | 0.052 | 0.059 | Phosphodiesterase 1C inhibitor | |||
| 0.076 | 0.069 | 0.076 | Bcr-Abl kinase inhibitor | |||
| 0.126 | 0.119 | 0.126 | MAP kinase 3 inhibitor | |||
| 0.055 | 0.049 | 0.055 | Sphingosine kinase inhibitor | |||
| 0.06 | 0.054 | 0.088 | Matrix metalloproteinase inhibitor | 0.088 0.032 CID_171625 | CID_171625 | |
| 0.06 | 0.054 | 0.06 | Transcription factor RelA inhibitor | |||
| 0.019 | 0.013 | 0.019 | Endothelin B receptor antagonist | |||
| 0.019 | 0.013 | 0.019 | Bombesin 3 receptor agonist | |||
| 0.009 | 0.003 | 0.009 | Insulin like growth factor 3 antagonist | |||
| 0.034 | 0.028 | 0.043 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 CID_171625 0.043 0.013 CID_6453558 | CID_6453558 | |
| 0.113 | 0.108 | 0.113 | Cyclooxygenase inhibitor | |||
| 0.081 | 0.075 | 0.081 | Bromodomain-containing protein 2 inhibitor | |||
| 0.05 | 0.044 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.055 | 0.05 | 0.067 | Carbonic anhydrase inhibitor | 0.066 0.042 CID_171625 0.067 0.041 CID_6453558 | CID_6453558 | |
| 0.047 | 0.041 | 0.061 | Beta 2 adrenoreceptor antagonist | 0.061 0.023 CID_171625 | CID_171625 | |
| 0.04 | 0.035 | 0.04 | GABA B receptor antagonist | |||
| 0.03 | 0.025 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.025 | 0.02 | 0.107 | Sodium/glucose cotransporter 2 inhibitor | 0.107 0.003 CID_6453558 | CID_6453558 | |
| 0.077 | 0.072 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.049 | 0.044 | 0.06 | Carbonic anhydrase I inhibitor | 0.06 0.035 CID_171625 | CID_171625 | |
| 0.018 | 0.015 | 0.038 | Antibiotic Anthracycline-like | 0.038 0.002 CID_6453558 | CID_6453558 | |
| 0.037 | 0.033 | 0.057 | Glucagon-like peptide 1 receptor antagonist | 0.057 0.009 CID_171625 | CID_171625 | |
| 0.011 | 0.007 | 0.011 | Thromboxane agonist | |||
| 0.021 | 0.017 | 0.021 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.017 | 0.013 | 0.017 | Aminopeptidase A inhibitor | |||
| 0.109 | 0.106 | 0.162 | Histone deacetylase SIRT1 inhibitor | 0.162 0.052 CID_171625 | CID_171625 | |
| 0.076 | 0.072 | 0.076 | Caspase 7 inhibitor | 0.076 0.072 CID_171625 | ||
| 0.019 | 0.016 | 0.019 | Kainate receptor 5 antagonist | |||
| 0.011 | 0.008 | 0.011 | Beta 3 adrenoreceptor agonist | |||
| 0.019 | 0.016 | 0.023 | Caspase 8 inhibitor | 0.023 0.009 CID_171625 | CID_171625 | |
| 0.092 | 0.089 | 0.104 | Nav1.4 sodium channel blocker | 0.104 0.07 CID_171625 | CID_171625 | |
| 0.013 | 0.011 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.045 | 0.043 | 0.051 | Bombesin 2 receptor antagonist | 0.051 0.032 CID_171625 | CID_171625 | |
| 0.012 | 0.01 | 0.012 | Carbonic anhydrase XI inhibitor | |||
| 0.017 | 0.016 | 0.03 | Estrogen-related receptor gamma agonist | 0.03 0.004 CID_171625 | CID_171625 | |
| 0.03 | 0.029 | 0.03 | Protein kinase C beta II inhibitor | |||
| 0.153 | 0.152 | 0.509 | Vasodilator | 0.509 0.011 CID_6453558 | CID_6453558 | |
| 0.052 | 0.052 | 0.053 | Acetyl-CoA transferase 2 inhibitor | 0.053 0.05 CID_6453558 | CID_6453558 | |
| 0.016 | 0.015 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_6453558 | CID_6453558 | |
| 0.023 | 0.024 | 0.062 | Lysine carboxypeptidase inhibitor | 0.062 0.006 CID_171625 | CID_171625 | |
| 0.037 | 0.038 | 0.04 | Plasmepsin II inhibitor | 0.04 0.032 CID_171625 | CID_171625 | |
| 0.023 | 0.024 | 0.1 | Sodium/glucose cotransporter inhibitor | 0.1 0.003 CID_6453558 | CID_6453558 | |
| 0.042 | 0.044 | 0.066 | Carbonic anhydrase XII inhibitor | 0.066 0.03 CID_6453558 | CID_6453558 | |
| 0.158 | 0.16 | 0.252 | DNA damaging | 0.162 0.155 CID_171625 0.252 0.079 CID_6453558 | CID_6453558 | |
| 0.042 | 0.044 | 0.052 | Metalloproteinase-3 inhibitor | 0.052 0.031 CID_171625 | CID_171625 | |
| 0.016 | 0.018 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 CID_171625 | CID_171625 | |
| 0.046 | 0.049 | 0.057 | Carbonic anhydrase II inhibitor | 0.057 0.037 CID_171625 | CID_171625 | |
| 0.057 | 0.06 | 0.074 | Histone deacetylase SIRT3 inhibitor | 0.074 0.023 CID_171625 | CID_171625 | |
| 0.05 | 0.054 | 0.081 | Carbonic anhydrase stimulant | 0.081 0.025 CID_171625 | CID_171625 | |
| 0.069 | 0.073 | 0.109 | Interferon agonist | 0.109 0.023 CID_6453558 | CID_6453558 | |
| 0.093 | 0.097 | 0.133 | Proteasome inhibitor | 0.133 0.056 CID_171625 | CID_171625 | |
| 0.055 | 0.059 | 0.091 | Nitric oxide donor | 0.057 0.054 CID_171625 0.091 0.014 CID_6453558 | CID_6453558 | |
| 0.005 | 0.01 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.004 CID_171625 | CID_171625 | |
| 0.057 | 0.063 | 0.088 | Interferon inducer | 0.088 0.018 CID_6453558 | CID_6453558 | |
| 0.038 | 0.045 | 0.049 | Potassium channel Kv1.3 blocker | 0.049 0.03 CID_171625 | CID_171625 | |
| 0.042 | 0.05 | 0.053 | Carbonic anhydrase IX inhibitor | 0.053 0.04 CID_6453558 | CID_6453558 | |
| 0.005 | 0.014 | 0.012 | Integrin alphaVbeta5 antagonist | 0.012 0.006 CID_171625 | CID_171625 | |
| 0.008 | 0.019 | 0.017 | Integrin beta2 antagonist | 0.017 0.005 CID_171625 | CID_171625 | |
| 0.023 | 0.035 | 0.033 | Trypsin I inhibitor | 0.033 0.023 CID_171625 | CID_171625 | |
| 0.086 | 0.1 | 0.158 | Folate antagonist | 0.158 0.019 CID_171625 | CID_171625 | |
| 0.035 | 0.049 | 0.079 | Thymidylate synthase inhibitor | 0.079 0.008 CID_171625 | CID_171625 | |
| 0.031 | 0.046 | 0.063 | Carbonic anhydrase IV inhibitor | 0.063 0.018 CID_171625 | CID_171625 | |
| 0.007 | 0.022 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_6453558 | CID_6453558 | |
| 0.01 | 0.026 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 CID_6453558 | CID_6453558 | |
| 0.012 | 0.028 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 CID_171625 | CID_171625 | |
| 0.065 | 0.082 | 0.071 | Chymotrypsin inhibitor | 0.071 0.068 CID_171625 | CID_171625 | |
| 0.007 | 0.024 | 0.025 | Egl nine homolog 2 inhibitor | 0.025 0.004 CID_171625 | CID_171625 | |
| 0.051 | 0.072 | 0.074 | Caspase 9 inhibitor | 0.074 0.028 CID_171625 | CID_171625 | |
| 0.032 | 0.053 | 0.068 | Estrogen agonist | 0.068 0.027 CID_6453558 | CID_6453558 | |
| 0.033 | 0.055 | 0.088 | Stearoyl-CoA desaturase inhibitor | 0.088 0.009 CID_171625 | CID_171625 | |
| 0.044 | 0.068 | 0.056 | Angiotensin-converting enzyme inhibitor | 0.056 0.035 CID_171625 | CID_171625 | |
| 0.049 | 0.074 | 0.07 | Lipocortins synthesis agonist | 0.07 0.021 CID_6453558 | CID_6453558 | |
| 0.026 | 0.051 | 0.043 | Toll-Like receptor 2 agonist | 0.043 0.027 CID_171625 | CID_171625 | |
| 0.032 | 0.057 | 0.06 | Matrix metalloproteinase 1 inhibitor | 0.06 0.031 CID_171625 | CID_171625 | |
| 0.015 | 0.041 | 0.025 | Dopamine D1 agonist | 0.025 0.012 CID_6453558 | CID_6453558 | |
| 0.027 | 0.054 | 0.384 | Erythropoietin receptor agonist | 0.384 0.004 CID_171625 | CID_171625 | |
| 0.028 | 0.058 | 0.326 | Glycine transporter 2 inhibitor | 0.326 0.004 CID_171625 | CID_171625 | |
| 0.02 | 0.05 | 0.033 | Calcitonin receptor agonist | 0.033 0.024 CID_171625 | CID_171625 | |
| 0.071 | 0.102 | 0.118 | ATPase (Vacuolar H+) inhibitor | 0.118 0.021 CID_6453558 | CID_6453558 | |
| 0.032 | 0.063 | 0.065 | Microtubule stabilization | 0.065 0.009 CID_6453558 | CID_6453558 | |
| 0.03 | 0.063 | 0.056 | Ribonucleoside-diphosphate reductase inhibitor | 0.056 0.037 CID_171625 | CID_171625 | |
| 0.005 | 0.038 | 0.014 | Integrin alpha4beta1 antagonist | 0.014 0.012 CID_171625 | CID_171625 | |
| 0.081 | 0.115 | 0.129 | Histone deacetylase class III inhibitor | 0.129 0.062 CID_171625 | CID_171625 | |
| 0.03 | 0.064 | 0.058 | Ribonucleotide reductase inhibitor | 0.058 0.037 CID_171625 | CID_171625 | |
| 0.046 | 0.081 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.053 CID_6453558 | CID_6453558 | |
| 0.035 | 0.073 | 0.055 | Aminopeptidase microsomal inhibitor | 0.055 0.044 CID_171625 | CID_171625 | |
| 0.037 | 0.078 | 0.069 | Glucagon-like peptide 1 agonist | 0.069 0.042 CID_171625 | CID_171625 | |
| 0.007 | 0.049 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 CID_171625 | CID_171625 | |
| 0.013 | 0.057 | 0.131 | Glucagon receptor antagonist | 0.131 0.004 CID_171625 | CID_171625 | |
| 0.03 | 0.075 | 0.045 | Integrin alpha1beta1 antagonist | 0.045 0.012 CID_171625 | CID_171625 | |
| 0.057 | 0.102 | 0.07 | Phosphodiesterase VI inhibitor | 0.07 0.063 CID_6453558 | CID_6453558 | |
| 0.078 | 0.126 | 0.185 | Beta amyloid protein antagonist | 0.185 0.022 CID_6453558 | CID_6453558 | |
| 0.008 | 0.057 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.011 CID_6453558 | CID_6453558 | |
| 0.025 | 0.075 | 0.054 | Antimetabolite | 0.054 0.029 CID_171625 | CID_171625 | |
| 0.028 | 0.084 | 0.056 | Plasminogen activator inhibitor | 0.056 0.043 CID_171625 | CID_171625 | |
| 0.112 | 0.168 | 0.168 | Interleukin 6 antagonist | 0.152 0.086 CID_171625 0.168 0.066 CID_6453558 | CID_6453558 | |
| 0.046 | 0.107 | 0.176 | Topoisomerase II alpha inhibitor | 0.176 0.019 CID_6453558 | CID_6453558 | |
| 0.01 | 0.07 | 0.023 | Corticosteroid-like | 0.023 0.012 CID_6453558 | CID_6453558 | |
| 0.067 | 0.13 | 0.092 | Hematopoietic | 0.092 0.046 CID_171625 | CID_171625 | |
| 0.052 | 0.119 | 0.071 | Potassium channel (Tandem pore domain) blocker | 0.071 0.061 CID_171625 | CID_171625 | |
| 0.033 | 0.104 | 0.056 | Cytokine production stimulant | 0.056 0.018 CID_6453558 | CID_6453558 | |
| 0.019 | 0.091 | 0.034 | Factor XIIIa inhibitor | 0.034 0.03 CID_171625 | CID_171625 | |
| 0.071 | 0.145 | 0.131 | Multidrug resistance-associated protein 1 inhibitor | 0.131 0.038 CID_6453558 | CID_6453558 | |
| 0.005 | 0.08 | 0.024 | VLA-4 antagonist | 0.024 0.019 CID_171625 | CID_171625 | |
| 0.082 | 0.181 | 0.293 | Anticoagulant | 0.22 0.047 CID_171625 0.293 0.029 CID_6453558 | CID_6453558 | |
| 0.013 | 0.113 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 CID_6453558 | CID_6453558 | |
| 0.098 | 0.2 | 0.146 | Antimitotic | 0.146 0.125 CID_6453558 | CID_6453558 | |
| 0.008 | 0.111 | 0.016 | Integrin beta6 antagonist | 0.016 0.006 CID_171625 | CID_171625 | |
| 0.12 | 0.223 | 0.177 | Cardiotonic | 0.177 0.143 CID_171625 | CID_171625 | |
| 0.012 | 0.115 | 0.069 | Integrin antagonist | 0.069 0.022 CID_171625 | CID_171625 | |
| 0.028 | 0.133 | 0.219 | Antineoplastic antibiotic | 0.219 0.018 CID_6453558 | CID_6453558 | |
| 0.004 | 0.114 | 0.02 | Integrin alpha4beta7 antagonist | 0.02 0.015 CID_171625 | CID_171625 | |
| 0.002 | 0.114 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_6453558 | CID_6453558 | |
| 0.037 | 0.155 | 0.105 | Histone deacetylase stimulant | 0.105 0.025 CID_6453558 | CID_6453558 | |
| 0.037 | 0.155 | 0.105 | Histone deacetylase SIRT1 stimulant | 0.105 0.025 CID_6453558 | CID_6453558 | |
| 0.015 | 0.14 | 0.052 | Integrin alpha5beta1 antagonist | 0.052 0.016 CID_171625 | CID_171625 | |
| 0.012 | 0.14 | 0.084 | Glycine transporter inhibitor | 0.084 0.015 CID_171625 | CID_171625 | |
| 0.005 | 0.14 | 0.019 | Vitronectin receptor antagonist | 0.019 0.016 CID_171625 | CID_171625 | |
| 0.061 | 0.197 | 0.096 | T cell inhibitor | 0.096 0.028 CID_171625 | CID_171625 | |
| 0.087 | 0.237 | 0.112 | Papain-like protease (SARS coronavirus) inhibitor | 0.112 0.106 CID_171625 | CID_171625 | |
| 0.125 | 0.278 | 0.157 | MAP kinase kinase 5 inhibitor | 0.157 0.127 CID_171625 | CID_171625 | |
| 0.094 | 0.248 | 0.539 | Tumour necrosis factor alpha release inhibitor | 0.539 0.011 CID_6453558 | CID_6453558 | |
| 0.036 | 0.192 | 0.278 | Topoisomerase I inhibitor | 0.278 0.013 CID_6453558 | CID_6453558 | |
| 0.007 | 0.188 | 0.022 | Integrin alphaVbeta3 antagonist | 0.022 0.015 CID_171625 | CID_171625 | |
| 0.005 | 0.186 | 0.053 | GP IIb/IIIa receptor antagonist | 0.053 0.031 CID_171625 | CID_171625 | |
| 0.017 | 0.204 | 0.112 | Protein 50S ribosomal subunit inhibitor | 0.112 0.01 CID_6453558 | CID_6453558 | |
| 0.017 | 0.215 | 0.079 | Antibiotic Aminoglycoside-like | 0.079 0.004 CID_6453558 | CID_6453558 | |
| 0.141 | 0.345 | 0.245 | Ca(v)3.3 blocker | 0.245 0.109 CID_171625 | CID_171625 | |
| 0.072 | 0.288 | 0.126 | Growth hormone agonist | 0.126 0.111 CID_171625 | CID_171625 | |
| 0.024 | 0.248 | 0.067 | Thrombin inhibitor | 0.067 0.059 CID_171625 | CID_171625 | |
| 0.022 | 0.273 | 0.106 | Protein kinase A inhibitor | 0.106 0.041 CID_6453558 | CID_6453558 | |
| 0.006 | 0.293 | 0.019 | Integrin alphaVbeta1 antagonist | 0.019 0.013 CID_171625 | CID_171625 | |
| 0.005 | 0.309 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 CID_6453558 | CID_6453558 | |
| 0.086 | 0.405 | 0.532 | Immunomodulator | 0.532 0.019 CID_6453558 | CID_6453558 | |
| 0.007 | 0.33 | 0.06 | Protein 30S ribosomal subunit inhibitor | 0.06 0.006 CID_6453558 | CID_6453558 | |
| 0.013 | 0.345 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 CID_6453558 | CID_6453558 | |
| 0.018 | 0.438 | 0.095 | DNA intercalator | 0.095 0.079 CID_6453558 | CID_6453558 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |